Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirban Basu

Showing results (1-10 of 471) with videos related to

Pageof 48
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 5, 2009
Individualization at the heart of comparative effectiveness research: the time for i-CER has comeAnirban Basu
Health Affairs (Project Hope)|May 8, 2020
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United StatesAnirban Basu
JAMA Health Forum|December 13, 2024
Mitigating Clinical Algorithmic DiscriminationAnirban Basu
Statistics in Medicine|October 12, 2012
Patient-centered or 'central' patient: Raising the veil of ignorance over randomizationAnirban Basu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2024
Financial Impacts of Paying for Gene Therapy for Sickle Cell Disease Under Alternative Pricing and Financing MechanismsAnirban Basu
Journal of Health Economics|January 24, 2020
A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implicationsAnirban Basu
Journal of Health Economics|May 24, 2011
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health careAnirban Basu
Expert Review of Pharmacoeconomics & Outcomes Research|December 9, 2014
Financing cures in the United StatesAnirban Basu
Schizophrenia Research|October 12, 2004
Cost-effectiveness analysis of pharmacological treatments in schizophrenia: critical review of results and methodological issuesAnirban Basu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 14, 2024
Logical Inconsistencies With Expected Utility Theory May Align Better With Patient Preferences-A Response to Paulden et alAnirban Basu
Pageof 48

Showing results (1-10 of 471) with videos related to

Sort By:
Pageof 48
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 5, 2009
Individualization at the heart of comparative effectiveness research: the time for i-CER has comeAnirban Basu
Health Affairs (Project Hope)|May 8, 2020
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United StatesAnirban Basu
JAMA Health Forum|December 13, 2024
Mitigating Clinical Algorithmic DiscriminationAnirban Basu
Statistics in Medicine|October 12, 2012
Patient-centered or 'central' patient: Raising the veil of ignorance over randomizationAnirban Basu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2024
Financial Impacts of Paying for Gene Therapy for Sickle Cell Disease Under Alternative Pricing and Financing MechanismsAnirban Basu
Journal of Health Economics|January 24, 2020
A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implicationsAnirban Basu
Journal of Health Economics|May 24, 2011
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health careAnirban Basu
Expert Review of Pharmacoeconomics & Outcomes Research|December 9, 2014
Financing cures in the United StatesAnirban Basu
Schizophrenia Research|October 12, 2004
Cost-effectiveness analysis of pharmacological treatments in schizophrenia: critical review of results and methodological issuesAnirban Basu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 14, 2024
Logical Inconsistencies With Expected Utility Theory May Align Better With Patient Preferences-A Response to Paulden et alAnirban Basu
Pageof 48